Increased prevalence of polyomavirus BK viruria that correlates with thrombocytopenia in patients with systemic lupus erythematosus on intensive immunosuppressive therapy

References

• Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1: 1253–1257
   PubMed Web of Science ®Google Scholar
• Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71: 115–123
   PubMed Web of Science ®Google Scholar
• Mathur VS, Olson JL, Darragh TM, Yen TS. Polyomavirus-induced interstitial nephritis in two renal transplant recipients: Case reports and review of the literature. Am J Kidney Dis 1997; 29: 754–758
   PubMed Web of Science ®Google Scholar
• Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488–496
   PubMed Web of Science ®Google Scholar
• Hirsch HH, Steiger J, Polyomavirus BK. Lancet Infect Dis 2003; 3: 611–623
   PubMed Web of Science ®Google Scholar
• Hirsch HH. BK virus: Opportunity makes a pathogen. Clin Infect Dis 2005; 41: 354–360
   PubMed Web of Science ®Google Scholar
• Reploeg MD, Storch GA, Clifford DB. BK virus: A clinical review. Clin Infect Dis 2001; 33: 191–202
   PubMed Web of Science ®Google Scholar
• Rekvig OP, Moens U, Sundsfjord A, et al. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Invest 1997; 99: 2045–2054
   PubMed Web of Science ®Google Scholar
• Taguchi F, Hara K, Nagaki D. BK papovavirus in urine of a patient with systemic lupus erythematosus. Acta Virol 1978; 22: 513–518
   PubMedGoogle Scholar
• Sundsfjord A, Osei A, Rosenqvist H, et al. BK and JC viruses in patients with systemic lupus erythematosus: Prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis 1999; 180: 1–9
   PubMed Web of Science ®Google Scholar
• VanGhelue M, Moens U, Bendiksen S, Rekvig OP. Autoimmunity to nucleosomes related to viral infection: A focus on hapten-carrier complex formation. J Autoimmun 2003; 20: 171–182
   PubMedGoogle Scholar
• Flaegstad T, Fredriksen K, Dahl B, Traavik T, Rekvig OP. Inoculation with BK virus may break immunological tolerance to histone and DNA antigens. Proc Natl Acad Sci USA 1988; 85: 8171–8175
   PubMedGoogle Scholar
• Fredriksen K, Traavik T, Flaegstad T, Rekvig OP. BK virus terminates tolerance to dsDNA and histone antigens in vivo. Immunol Invest 1990; 19: 133–151
   PubMed Web of Science ®Google Scholar
• Bredholt G, Olaussen E, Moens U, Rekvig OP. Linked production of antibodies to mammalian DNA and to human polyomavirus large T antigen: Footprints of a common molecular and cellular process?. Arthritis Rheum 1999; 42: 2583–2592
   PubMedGoogle Scholar
• Bendiksen S, Van Ghelue M, Winkler T, Moens U, Rekvig OP. Autoimmunity to DNA and nucleosomes in binary tetracycline-regulated polyomavirus T-Ag transgenic mice. J Immunol 2004; 173: 7630–7640
   PubMedGoogle Scholar
• Bendiksen S, Rekvig OP, Van Ghelue M, Moens U. VP1 DNA sequences of JC and BK viruses detected in urine of systemic lupus erythematosus patients reveal no differences from strains expressed in normal individuals. J Gen Virol 2000; 8: 2625–2633
   Google Scholar
• Chang D, Tsai RT, Wang M, Ou WC. Different genotypes of human polyomaviruses found in patients with autoimmune diseases in Taiwan. J Med Virol 1996; 48: 204–209
   PubMedGoogle Scholar
• Bendiksen S, Mortensen ES, Olsen R, et al. Glomerular expression of large polyomavirus T antigen in binary tet-off regulated transgenic mice induces apoptosis, release of chromatin and initiates a lupus-like nephritis. Mol Immunol 2008; 45: 728–739
   PubMedGoogle Scholar
• Bressollette-Bodin C, Coste-Burel M, Hourmant M, Sebille V, Andre-Garnier E, Imbert-Marcille BM. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 2005; 5: 1926–1933
   PubMed Web of Science ®Google Scholar
• Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transpl 2000; 15: 324–332
   PubMed Web of Science ®Google Scholar
• Colla L, Mesiano P, Morellini V, et al. Human polyomavirus BK in patients with lupus nephritis: clinical and histological correlations. Lupus 2007; 16: 881–886
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Randhawa P, Ho A, Shapiro R, et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 2004; 42: 1176–1180
   PubMed Web of Science ®Google Scholar
• Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005; 352: 1157–1158
   PubMed Web of Science ®Google Scholar
• Rekvig OP, Bendiksen S, Moens U. Immunity and autoimmunity induced by polyomaviruses: Clinical, experimental and theoretical aspects. Adv Exp Med Biol 2006; 577: 117–147
   PubMedGoogle Scholar
• Liebman HA, Stasi R. Secondary immune thrombocytopenic purpura. Curr Opin Hematol 2007; 14: 557–573
   PubMed Web of Science ®Google Scholar
• Rand ML, Wright JF. Virus-associated idiopathic thrombocytopenic purpura. Transfus Sci 1998; 19: 253–259
   PubMedGoogle Scholar
• Howley PM, Khoury G, Byrne JC, Takemoto KK, Martin MA. Physical map of the BK virus genome. J Virol 1975; 16: 959–973
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005; 38: 473–485
   PubMed Web of Science ®Google Scholar
• Von Landenberg P, Lehmann HW, Knöll A, Dorsch S, Modrow S. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 2003; 48: 1939–1947
   PubMedGoogle Scholar
• Suzuki T, Saito S, Hirabayashi Y, et al. Human parvovirus B19 infection during the inactive stage of systemic lupus erythematosus. Intern Med 2003; 42: 538–540
   PubMedGoogle Scholar
• Mitsunaka H, Tokuda M, Takahara J, Matoba K, Miyawaki S. A case of systemic lupus erythematosus with pure red cell aplasia possibly caused by persistent infection of human parvovirus B19. Nihon Rinsho Meneki Gakkai Kaishi 1998; 21: 220–225
   PubMedGoogle Scholar
• von Landenberg P, Lehmann HW, Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun Rev 2007; 6: 278–285
   PubMed Web of Science ®Google Scholar
• Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2003; 2: 218–223
   PubMed Web of Science ®Google Scholar
• Franchini M, Cruciani M, Mengoli C, Pizzolo G, Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: A systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 237–246
   PubMed Web of Science ®Google Scholar